Health Secretary Robert F. Kennedy Jr. said Tuesday the goal is to widen access to peptides through a regulated marketplace, Reuters reports.
Recap by typeshit. Full story at Reuters on MSN.
The FDA plan would let pharmacies compound peptides like BPC-157 under enforcement discretion, even though agency scientists say safety is unproven.
A man says Mounjaro and Trulicity caused his gastroparesis, and the clip walks through who must warn patients about side effects under Indiana law.
Alicia Butterfield claims Anthem denied her Zepbound once the drug got her below morbid obesity. A Los Angeles judge stayed her case pending arbitration.
STAT
Members of Congress from both parties want the FDA to stop imports of copycat versions of Eli Lilly's experimental obesity drug, which is still in trials.
A sponsored-style explainer from telehealth provider Mochi Health on what the end of shortages means for compounded semaglutide and tirzepatide.
32:34
The German investigative YouTube team looks at the business behind peptides and who profits from their rising popularity.
Loading…